Provider QP87-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Strensiq® (asfotase alfa) Read More
Provider QP86-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) Criteria: Vtama® (tapinarof) Read More
Provider QP84-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Camzyos™ (mavacamten) Read More
Provider QP85-22 MHCP Pharmacy Benefit Update: New drug-related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Radicava® (edaravone) Read More
Provider QP83-22 MHCP Pharmacy Benefit Exclusion for Somatuline® Depot and Sandostatin® LAR Depot Read More
Provider QP82-22 MHCP Pharmacy Benefit Update New drug-related PA with QL Criteria Vijoice® (alpelisib) Read More
Provider QP80-22 Commercial Pharmacy Benefit Update: New and Revised Drug-Related PA Requirement Notification, Effective December 1, 2022 Read More
